Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 19:34:67-74.
doi: 10.1016/j.ctro.2022.03.005. eCollection 2022 May.

"Radiotherapy for thymic epithelial tumors: What is the optimal dose? A systematic review."

Affiliations
Review

"Radiotherapy for thymic epithelial tumors: What is the optimal dose? A systematic review."

A Angrisani et al. Clin Transl Radiat Oncol. .

Abstract

Thymic epithelial tumors (TETs) are rare thoracic tumors, often requiring multimodal approaches. Surgery represents the first step of the treatment, possibly followed by adjuvant radiotherapy (RT) and, less frequently, chemotherapy. For unresectable tumors, a combination of chemotherapy and RT is often used. Currently, the optimal dose for patients undergoing radiation is not clearly defined. Current guidelines on RT are based on studies with a low level of evidence, where 2D RT was widely used. We aim to shed light on the optimal radiation dose for patients with TETs undergoing RT through a systematic review of the recent literature, including reports using modern RT techniques such as 3D-CRT, IMRT/VMAT, or proton-therapy. A comprehensive literature search of four databases was conducted following the PRISMA guidelines. Two investigators independently screened and reviewed the retrieved references. Reports with < 20 patients, 2D-RT use only, median follow-up time < 5 years, and reviews were excluded. Two studies fulfilled all the criteria and therefore were included. Loosening the follow-up time criteria to > 3 years, three additional studies could be evaluated. A total of 193 patients were analyzed, stratified for prognostic factors (histology, stage, and completeness of resection), and synthesized according to the synthesis without meta-analysis (SWIM) method. The paucity and heterogeneity of eligible studies led to controversial results. The optimal RT dose neither for postoperative, nor primary RT in the era of modern RT univocally emerged. Conversely, this overview can spark new evidence to define the optimal RT dose for each TETs category.

Keywords: Radiation dose; Radiotherapy; TETs; Thymic carcinoma; Thymoma.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Preferred Reporting Items for Systematic Reviews and Meta-Analyses flowchart. Note: Two studies were included according to all the pre-specified inclusion and exclusion criteria.Three additional studies were separately analyzed after the first synthesis of data; however, they did not satisfy the median follow-up time criteria, thus they are not shown between the included ones.

References

    1. Carter B.W., Okumura M., Detterbeck F.C., Marom E.M. Approaching the patient with an anterior mediastinal mass: a guide for radiologists. J Thorac Oncol. 2014;9:S110–S118. doi: 10.1097/JTO.0000000000000295. - DOI - PubMed
    1. Carter B.W., Benveniste M.F., Madan R., Godoy M.C., de Groot P.M., Truong M.T., et al. ITMIG Classification of Mediastinal Compartments and Multidisciplinary Approach to Mediastinal Masses. Radiographics. 2017;37(2):413–436. - PubMed
    1. Marx A., Ströbel P., Badve S.S., Chalabreysse L., Chan J.K.C., Chen G., et al. ITMIG consensus statement on the use of the WHO histological classification of thymoma and thymic carcinoma: refined definitions, histological criteria, and reporting. J Thorac Oncol. 2014;9(5):596–611. - PubMed
    1. Marx A., Chan J.K.C., Coindre J.-M., Detterbeck F., Girard N., Harris N.L., et al. The 2015 World Health Organization Classification of Tumors of the Thymus: Continuity and Changes. J Thorac Oncol. 2015;10(10):1383–1395. - PMC - PubMed
    1. Girard N., Ruffini E., Marx A., Faivre-Finn C., Peters S. Thymic epithelial tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(Suppl 5):v40–v55. doi: 10.1093/annonc/mdv277. - DOI - PubMed